Auranofin treatment in early rheumatoid arthritis may postpone early retirement. Results from a 2-year double blind trial.
about
Evidence for early disease-modifying drugs in rheumatoid arthritisOnly high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategyWhich patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS).Predictive factors of work disability in rheumatoid arthritis: a systematic literature reviewWork disability among two cohorts of women with recent-onset rheumatoid arthritis: a survival analysisWork disability in scleroderma is greater than in rheumatoid arthritis and is predicted by high HAQ scores.
P2860
Auranofin treatment in early rheumatoid arthritis may postpone early retirement. Results from a 2-year double blind trial.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Auranofin treatment in early r ...... m a 2-year double blind trial.
@en
type
label
Auranofin treatment in early r ...... m a 2-year double blind trial.
@en
prefLabel
Auranofin treatment in early r ...... m a 2-year double blind trial.
@en
P2093
P1476
Auranofin treatment in early r ...... m a 2-year double blind trial.
@en
P2093
P304
P407
P577
1991-07-01T00:00:00Z